Belviq, manufactured by Arena Pharmaceuticals and distributed by Eisai Inc., is a weight loss drug prescribed for weight management of health conditions, including diabetes and high blood pressure. Eisai conducted an FDA-mandated five-year double-blind study with over 12,000 participants. The study showed that Belviq usage increased the risk of pancreatic, colorectal, and lung cancer, prompting an FDA recall of Belviq nationwide in February 2020.
Contacting 1-800-LAW-FIRM is the best way to determine if you have a case against the manufacturer.
Receive a free confidential and no-obligation case review today, it can take as little as five minutes to see if you qualify!